The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review
出版年份 2021 全文链接
标题
The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review
作者
关键词
-
出版物
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-10
DOI
10.1007/s00787-021-01748-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Economics and mental health: the current scenario
- (2020) Martin Knapp et al. World Psychiatry
- Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018
- (2020) David D. Kim et al. PHARMACOECONOMICS
- Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions
- (2019) Pei-Jung Lin et al. PHARMACOECONOMICS
- The economic burden of adult attention deficit hyperactivity disorder: A sibling comparison cost analysis
- (2019) D. Daley et al. EUROPEAN PSYCHIATRY
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
- (2019) Mark L. Wolraich et al. PEDIATRICS
- Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis
- (2018) Javier Quintero et al. BMC Psychiatry
- Family Spillover Effects in Pediatric Cost-Utility Analyses
- (2018) Tara A. Lavelle et al. Applied Health Economics and Health Policy
- A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years
- (2017) Edmund J. S. Sonuga-Barke et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Cost Offset Associated With Early Start Denver Model for Children With Autism
- (2017) Zuleyha Cidav et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The influence of time horizon on results of cost-effectiveness analyses
- (2017) David D. Kim et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges
- (2017) Ramesh Lamsal et al. Applied Health Economics and Health Policy
- Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
- (2016) Jean Lachaine et al. BMC Psychiatry
- A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate
- (2016) Evelina A. Zimovetz et al. CNS DRUGS
- How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)
- (2016) Ghislaine A.P.G. van Mastrigt et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial
- (2015) Sarah Byford et al. BMC Psychiatry
- Prevalence of Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
- (2015) R. Thomas et al. PEDIATRICS
- Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?
- (2015) Saskia Schawo et al. PHARMACOECONOMICS
- A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations
- (2015) Gang Chen et al. PHARMACOECONOMICS
- Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
- (2015) Carlos R. Maia et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
- (2015) Jurjen van der Schans et al. PLoS One
- Annual Research Review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders
- (2014) Jennifer Beecham JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Economic Burden of Childhood Autism Spectrum Disorders
- (2014) T. A. Lavelle et al. PEDIATRICS
- Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
- (2013) Hoa H. Le et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
- (2013) M. Haim Erder et al. Applied Health Economics and Health Policy
- Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
- (2012) Eric Q. Wu et al. CNS DRUGS
- Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
- (2012) Vanja Sikirica et al. PHARMACOECONOMICS
- Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics
- (2009) Allan L. Reiss JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started